患者様やご家族など一般の方向け臨床・治癒情報サイト　臨床研究情報ポータルサイト

• 進捗状況
• 試験名
• 対象疾患名
• 国名
• 登録日
•  

• Recruiting

• A Phase 1/2 Multicenter, Randomized, Placebo-Controlled Double-Blind, Parallel Group Study to Evaluate the Safety and Efficacy of Two Regimens of a Candidate Topical NF kappaB Decoy in the Treatment of Adults with Mild to Moderate Atopic Dermatitis
• Atopic dermatitis
• Australia
• 2005-09-14

• Recruiting

• Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)- Measure Up 1
• Atopic Dermatitis
• Argentina, Australia, Bosnia and Herzegovina, Bulgaria, Canada, China, Colombia, Croatia, Denmark, Estonia, Finland, France, Germany, Italy, Japan, Malaysia, New Zealand, Puerto Rico, Romania, Russian Federation, Switzerland, Turkey, Ukraine, United Kingdom, United States
• 2018-06-14

• Recruiting

• Effects of A1 versus A2 milk on cardiometabolic risk in overweight and obese Australians
• Overweight and obesity;Cardiometabolic risk factors related to A1 beta-casein;Gastrointestinal symptoms related to A1 beta-casein; Overweight and obesity Cardiometabolic risk factors related to A1 beta-casein Gastrointestinal symptoms related to A1 beta-casein;Cardiovascular - Diseases of the vasculature and circulation including the lymphatic system;Diet and Nutrition - Obesity;Inflammatory and Immune System - Other inflammatory or immune system disorders
• Australia
• 2017-03-17

• Recruiting

• A Phase I clinical trial to evaluate the safety and pharmacokinetics of SHR0302 base ointment at single dose and multiple dose in healthy adult subjects
• Atopic dermatitis; Atopic dermatitis;Skin - Dermatological conditions
• Australia
• 2019-10-17

• Recruiting

• Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease
• Alzheimer's Disease
• Australia, Bulgaria, Canada, Czech Republic, Czechia, Hungary, Poland, United States
• 2015-09-10

• Recruiting

• A Phase III Case Series Clinical Study of the Reversal of the Anticoagulant Effects of Dabigatran by Intravenous Administration of 5.0g Idarucizumab (BI 655075) in Patients Treated Wtih Dabigatran Etexilate Who Have Uncontrolled Bleeding or Require Emergency Surgery or Procedures.RE-VERSE AD (A Study of the RE-VERSal Effects of Idarucizumab on Active Dabigatran) Trial
• Hemorrhage;D68.3 - Haemorrhagic disorder due to circulating anticoagulants
• Argentina, Australia, Austria, Belgium, Canada, Chile, Colombia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Hong Kong, Ireland, Israel, Italy, Korea, Republic of, Latvia, Mexico, Netherlands, New Zealand, Norway, Poland, Portugal, Russian Federation, Singapore, Slovakia, South Africa, Spain, Sweden, Taiwan, Province of China, United Kingdom, United States
• 2015-07-22

• Recruiting

• The effect of adding magnesium sulphate to fentanyl and bupivacaine for spinal anaesthesia in patients undergoing lower limb orthopedic surgery
• duration of spinal anaesthesia in lower limb orthopedic surgery
• Egypt
• 2015-05-20

• Recruiting

• Detection of Individuals with Preclinical, Prodromal and Mild Alzheimer's Disease for Therapeutic Trials.
• Preclinical Alzheimer's Disease;Prodromal Alzheimer's Disease;Mild Alzheimer's Disease
• Australia
• 2015-01-21

• Recruiting

• Longitudinal study of early Alzheimer's disease using genetics, brain imaging and behavioural assessments.
• dementia;Mild cognitive impairment;Alzheimer's disease
• Australia
• 2016-11-16

• Recruiting

• Investigating the Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) as a Treatment for Alzheimer's Disease
• Alzheimer's Disease
• Australia, Canada
• 2016-09-13